India's Panacea Biotec up on getting antiviral registration in Germany

Panacea Biotec

15/12/2023 04:21

** Shares of Panacea Biotec  PNCA.NS  rise as much as 8.83%
to 177.5 rupees
    ** Co said on Thursday it received registration of
Valganciclovir powder for oral solution in Germany
    ** The powder is an antiviral used to treat infections
caused by viruses
    ** Co also launched EasyFourPol, a vaccine for tetanus,
polio, and other invasive infections
    ** More than 650,000 shares change hands, 2.9x its 30-day
avg
    ** Including sessions gains, stock up 20% YTD


 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))